Interplay Learning ranks No. 10 on Austin Business Journal’s fastest-growing private companies List
The leader in VR and simulation-based training for the skilled trades has been honored for its contributions to the local economy and business community AUSTIN,... Read more.
e-STORAGE to Deliver 408 MWh Battery Energy Storage System for Vena Energy in South Australia
KITCHENER, ON, Dec. 17, 2025 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced... Read more.
Bioptimus Unveils M-Optimus, a World Model for Biology
Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation... Read more.
Warner Bros. Discovery Board of Directors Unanimously Recommends Shareholders Reject Paramount Tender Offer
Reiterates Recommendation in Support of Netflix Combination, Which Represents Superior, More Certain Value for Shareholders Paramount Offer Reflects Inadequate Value... Read more.
National and Texas Leaders Convene at the George W. Bush Presidential Center to Advance Sustainable Local News
The meeting, hosted at the George W. Bush Institute with More Perfect, the American Journalism Project, and Press Forward, explored the growth of nonprofit local... Read more.
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Non-dilutive strategic transaction expected to extend cash runway into 2029, to advance Compugen’s innovative immuno-oncology pipeline and to reach potential... Read more.
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
PITTSBURGH, Dec. 17, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will present at the 44th... Read more.
Sealed Air Announces Expiration of “Go-Shop” Period
Transaction is Expected to Close in Mid-2026 CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ — Sealed Air Corporation (“Sealed Air” or the “Company”)... Read more.
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
Partnership combines Protalix’s rare disease and biologics expertise with Secarna’s AI–powered OligoCreator® platform to jointly develop pharmaceutical... Read more.
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after surgery... Read more.